For example, in mice bearing recurrent B16 melanoma tumors, full tumor regression could only be achieved when anti-PD-L1 treatment was combined with Treg cell depletion or blockade of the inhibitory receptor LAG-3 [33]. This evidence concerns the gene LAG3 and neoplasm.